Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR

Japanese Journal of Cancer Research

Volumn 93, Issue 12, 2002, Pages 1342-1350

  Fujiwara, Hisataka ^a   Terashima, Masanori ^b   Irinoda, Takashi ^a   Takagane, Akinori ^a   Abe, Kaoru ^a   Kashiwaba, Masahiro ^a   Oyama, Kennichi ^a   Takahashi, Masanori ^a   Maesawa, Chihaya ^a   Saito, Kazuyoshi ^a   Takechi, Teiji ^c   Fukushima, Masakazu ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Chemosensitivity testing; Dihydropyrimidine dehydrogenase; Gastric cancer; Real time RT PCR; Thymidylate synthase

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEASUREMENT; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; STOMACH CANCER; TUMOR GROWTH; XENOGRAFT;

EID: 0036949814     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01243.x     Document Type: Review

References (33)

1. Macdonald, J. S. and Gohmann, J. J. Chemotherapy of advanced gastric cancer: present, future prospects. Semin. Oncol., 15 (Suppl. 4), 42-49 (1988).
2. Murad, A. M., Santiago, F. F., Petroianu, A., Rocha, P. R., Rodrigues, M. A. and Rausch, M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer, 72, 37-41 (1993).
3. Kawamura, H., Ikeda, K., Takiyama, I. and Terashima, M. The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer. Eur. J. Cancer, 33, 960-966 (1997).
4. Kelsen, D., Atiq, O. T., Saltz, L., Niedzwiecki, D., Ginn, D., Chapman, D., Heelan, R., Lightdale, C., Vinciguerra, V. and Brennan, M. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. J. Clin. Oncol., 10, 541-548 (1992).
5. Schipper, D. L. and Wagener, D. J. Chemotherapy of gastric cancer. Anticancer Drugs, 7, 137-149 (1996).
6. Carrico, C. K. and Glazer, R. I. Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. Cancer Res., 39, 3694-3701 (1979).
7. Langenbach, R. J., Danenberg, P. V. and Heidelberger, C. Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem. Biophys. Res. Commun., 48, 1565-1571 (1972).
8. Parker, W. B. and Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther., 48, 381-395 (1990).
9. Beck, A., Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Renee, N. and Milano, G. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur. J. Cancer, 10, 1517-1522 (1994).
10. Peters, G. J., van der Wilt, C. L. and van Groeningen, C. J. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase. Eur. J. Cancer, 10, 1408-1411 (1994).
11. Johnston, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V. and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55, 1407-1412 (1995).
12. Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J. and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14, 176-182 (1996).
13. Heggie, G. D., Sommadossi, J. P., Cross, D. S., Huster, W. J. and Diasio, R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res., 47, 2203-2206 (1987).
14. Diasio, R. B. Clinical implications of dihydropyrimidine dehydrogenase inhibition. Oncology (Huntingt), 13 (Suppl. 3), 17-21 (1999).
15. Fischel, J. L., Formento, P., Etienne, M. C., Spector, T., Renee, N. and Milano, G. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor. Biochem. Pharmacol., 53, 1703-1709 (1997).
16. Ishikawa, Y., Kubota, T., Otani, Y., Watanabe, M., Teramoto, T., Kumai, K., Takechi, T., Okabe, H., Fukushima, M. and Kitajima, M. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice. Clin. Cancer Res., 5, 883-889 (1999).
17. Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renee, N., Schneider, M., Thyss, A., Demard, F. and Milano, G. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J. Clin. Oncol., 13, 1663-1670 (1995).
18. Terashima, M., Irinoda, T., Fujiwara, H., Nakaya, T., Takagane, A., Abe, K., Yonezawa, H., Oyama, K., Inaba, T., Saito, K., Takechi, T. and Fukushima, M. Role of thymidylate synthase and dihydropyrimidine dehydrogenase on tumor progression and sensitivity to 5-fluorouracil in human gastric cancer. Anticancer Res., 22, 761-768 (2002).
19. Johnston, S. J., Ridge, S. A., Cassidy, J. and McLeod, H. L. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer. Clin. Cancer Res., 5, 2566-2570 (1999).
20. Leichman, C. G., Lenz, H. J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M. and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol., 15, 3223-3229 (1997).
21. Ishikawa, Y., Kubota, T., Otani, Y., Watanabe, M., Teramoto, T., Kumai, K., Takechi, T., Okabe, H., Fukushima, K. and Kitajima, M. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil. Jpn. J. Cancer Res., 91, 105-112 (2000).
22. Johnson, M. R., Wang, K., Smith, J. B., Heslin, M. J. and Diasio, R. B. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal. Biochem., 278, 175-184 (2000).
23. Kasahara, M., Takahashi, Y., Nagata, T., Asai, S., Eguchi, T., Ishii, Y., Fujii, M. and Ishikawa, K. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Clin. Cancer Res., 6, 2707-2711 (2000).
24. Uchida, K., Hayashi, K., Kuramochi, H. and Takasaki, K. Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion. Int. J. Oncol., 19, 341-346 (2001).
25. Shirota, Y., Stoehlmacher, J., Brabender, J., Xiong, Y. P., Uetake, H., Danenberg, K. D., Groshen, S., Denise, D., Tasao-Wei, D. D., Danenberg, P. V. and Lenz, H. J. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol., 19, 4298-4304 (2001).
26. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer, 1, 10-24 (1998).
27. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br. J. Cancer, 77, 1-10 (1998).
28. Ishikawa, Y., Kubota, T., Otani, Y., Watanabe, M., Teramoto, T., Kumai, K., Takechi, T., Okabe, H., Fukushima, M. and Kitajima, M. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer. Anticancer Res., 19, 5635-5640 (1999).
29. Takechi, T., Okabe, H., Fujioka, A., Murakami, Y. and Fukushima, M. Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice. Jpn. J. Cancer Res., 89, 1144-1153 (1998).
30. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
31. Zhang, Z. G., Harstrick, A. and Rustum, Y. M. Mechanisms of resistance to fluoropyrimidines. Semin. Oncol., 19 (Suppl. 3), 4-9 (1992).
32. Johnston, P. G., Drake, J. C., Trepel, J. and Allegra, C. J. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res., 52, 4306-4312 (1992).
33. Mirjolet, J. F., Barberi-Heyob, M., Merlin, J. L., Marchal, S., Etienne, M. C., Milano, G. and Bey, P. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity. Br. J. Cancer, 78, 62-68 (1998).